SPOTLIGHT: Hikal wins Pfizer manufacturing deal

An Indian contract manufacturing company is jumping for joy after Pfizer chose it as a supplier of active pharmaceutical ingredients. Hikal will make the APIs at its FDA-approved manufacturing plant in Bangalore. Interestingly, the Indian company had been considering a buyout of Pfizer's Ireland operations, but dropped out of the bidding. Release

Suggested Articles

Johnson & Johnson has expanded its COVID-19 vaccine production pact with CDMO Catalent to include work at the manufacturer's Anagni, Italy site.

German vaccine maker CureVac scored an $85 million EU loan to expand manufacturing for its mRNA-based COVID-19 vaccine hopeful.

Learn how drug substance and drug product early development strategies are important for optimization and long-term success.